|
Symbol
|
KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | OLRRCH | KYIZDU | KYIJDU | OKXRCH | KYKCDU | RMA7YV | KYKTDU | KYKNDU | KYGYDU | KYLSDU | KYNDDU | RMBBDV | AANUTQ | OQTRCH | KYNWDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Givaudan / Partners Group Hldg. AG / Sika AG | ABB / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Partners Group Hldg. AG / Swiss RE AG | ABB N / Givaudan / Partners Group Hldg. AG | Givaudan / Nestlé N / Partners Group Hldg. AG | Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS / UBS Group AG | Adecco Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | Partners Group Hldg. AG / Swiss RE AG / Zurich Insurance Group AG | ABB / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | Julius Baer Group / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS | Givaudan / Partners Group Hldg. AG / Sika AG / UBS Group AG | Compagnie Financière Richemont SA / Partners Group Hldg. AG / Sika AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 01.07.2026 | 10.07.2026 | 10.07.2026 | 24.06.2026 | 17.07.2026 | 05.01.2027 | 24.07.2026 | 24.07.2026 | 03.07.2026 | 31.07.2026 | 10.08.2026 | 18.01.2027 | 05.08.2026 | 05.08.2026 | 14.08.2026 |
| Demande | 94,80 | - | 98,42 | 95,70 | - | 59,41 | 93,55 | 88,65 | 100,77 | - | 80,94 | - | - | - | - | 91,45 | - | - | 56,73 | - |
| Offre | 95,80 | - | - | 96,70 | - | - | 94,55 | 89,65 | - | - | - | - | - | - | - | 92,45 | - | - | - | - |